title: Non-steroidal anti-inflammatory drugs inhibit epinephrine- and cAMP-mediated lipolysis in isolated rat adipocytes.
abstract: Acute ethanol intoxication increased triacylglycerides (TAG) and thiobarbituric acid reactive substances (TBARS) in liver and promoted the liberation of epinephrine. Four non-steroidal anti-inflammatory drugs (NSAIDs)--aspirin, naproxen, nimesulide and piroxicam--prevented this increase in TAG and TBARS. Because fatty acids provided by adipose tissue contribute substantially to elevated hepatic TAG in ethanol-intoxicated rats, it was thought that the NSAIDs might reduce epinephrine-stimulated lipolysis in these rats. Isolated rat adipocytes were activated with epinephrine in the presence or absence of the NSAIDs. The NSAIDs inhibited epinephrine-stimulated lipolysis. These drugs did not modify the binding of dihydroalprenolol (beta-adrenergic agonist) to their receptors in isolated guinea-pig liver membranes. The NSAIDs, at concentrations 3,000-fold lower than that of cAMP, inhibited stimulated lipolysis by this messenger. In conclusion, aspirin, naproxen, nimesulide and piroxicam reduce the release of fatty acids from adipose tissue to the liver by inhibiting the epinephrine-stimulated lipolysis, and this, in part, explains the protective action of these NSAIDs against hepatic signs of acute ethanol intoxication.
authors: Department of Biochemistry, School of Medicine, National University of Mexico, DF. martha@laguna.fmedic.unam.mx
authors: Piña M
authors: PM
authors: de Zentella
authors: H
authors: H
authors: Vázquez-Meza
authors: G
authors: G
authors: Piña-Zentella
authors: L
authors: L
authors: Pimentel
authors: E
authors: E
authors: Piña
mesh_terms: D017667:Adipocytes / Q000187:drug effects* / Q000378:metabolism; D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D003994:Bucladesine / Q000494:pharmacology*; D004082:Dihydroalprenolol / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004837:Epinephrine / Q000494:pharmacology*; D000431:Ethanol / Q000494:pharmacology; D005990:Glycerol / Q000378:metabolism; D006168:Guinea Pigs; D008066:Lipolysis / Q000187:drug effects*; D008297:Male; D009288:Naproxen / Q000494:pharmacology; D010894:Piroxicam / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D013449:Sulfonamides / Q000494:pharmacology; D017392:Thiobarbituric Acid Reactive Substances / Q000378:metabolism; D014280:Triglycerides / Q000378:metabolism
chemical_list: D000318:Adrenergic beta-Agonists; D000894:Anti-Inflammatory Agents, Non-Steroidal; D013449:Sulfonamides; D017392:Thiobarbituric Acid Reactive Substances; D014280:Triglycerides; D010894:Piroxicam; D000431:Ethanol; D009288:Naproxen; D004082:Dihydroalprenolol; D003994:Bucladesine; D005990:Glycerol; D001241:Aspirin; C012655:nimesulide; D004837:Epinephrine